Table 1 Demographic and Baseline Characteristics of Patients
Characteristic | Population (n = 311) |
|---|---|
Age, mean ± SD | 40 (21–68) |
Female, n (%) | 299 (96.1) |
Region, n (%) | Â |
Java-Bali | 260 (84) |
Outside Java-Bali | 51 (16) |
Region Level of PPKM (2nd Wave, August 2021), n (%) | Â |
1 | 0 (0) |
2 | 5 (1.6) |
3 | 61 (19.6) |
4 | 245 (78.8) |
Rheumatic Condition, n (%) | Â |
Systemic Lupus Erythematosus | 217 (70.1) |
Rheumatoid Arthritis | 86 (27.3) |
Systemic Sclerosis/Scleroderma | 23 (7.4) |
Sjogren Syndrome | 20 (6.4) |
Ankylosing Spondylitis | 7 (2.3) |
Psoriatic Arthritis | 7 (2.3) |
Vasculitis | 5 (1.6) |
Medications, n (%) | Â |
Non-Biologic DMARD | 231 (74.3) |
Glucocorticoid | 222 (71.4) |
Anti-Malaria | 63 (20.3) |
No medication therapy | 9 (2.9) |
Biologic Agent | 6 (1.9) |
Type of Health Care Disruption, n (%) | Â |
Need to avoid a hospital visit | 81 (26.0) |
Stopped medication without medical advice | 76 (24.4) |